Страна: Сингапур
Язык: английский
Источник: HSA (Health Sciences Authority)
CLOBAZAM
SANOFI-AVENTIS SINGAPORE PTE. LTD.
N05BA09
10 mg
TABLET
CLOBAZAM 10 mg
ORAL
Prescription Only
Opella Healthcare International SAS
ACTIVE
1988-06-01
FRISIUM ® 10MG _Clobazam _ [sanofi logo] Tablets COMPOSITION Each tablet contains 10mg clobazam as active ingredient. Excipients: Lactose, maize starch, colloidal anhydrous silica, talc, magnesium stearate. INDICATIONS Acute and chronic anxiety states, which may produce the following symptoms in particular: Anxiety, tension, restlessness, excitement, irritability, sleep disturbances from emotional causes, psychovegetative and psychosomatic disorders (for example, in the cardiovascular or gastro-intestinal area), and emotional instability. In cases of psychovegetative and psychosomatic disorders, the doctor should investigate the possibility of an organic cause. Before treatment of anxiety states associated with emotional instability, it must first be determined whether the patient suffers from a depressive disorder requiring adjuvant of different treatment. - As adjunctive therapy in patients with epilepsy who are not adequately stabilized with their anticonvulsant mono-therapy. CONTRAINDICATIONS Frisium10 must not be used In patients with hypersensitivity to clobazam or any of the excipients, or with any history of drug dependence. In patients with myasthenia gravis (risk of aggrevation of muscle weakness) In patients with severe respiratory insufficiency (risk of deterioration) In patients with sleep apnoea syndrome (risk of deterioration) In patients with severe impairment of liver function (risk of precipitating encephalopathy) In breast-feeding women During the first trimester of pregnancy(for use during second and third trimester, see section Fertility, Pregnancy and Lactation) Benzodiazepines must not be given to children without careful assessment of the need for their use. Children between the ages of 6 months and 3 years should not normally be given Frisium10; however, in exceptional cases, where there are compelling indications, it can be used for anticonvulsant treatment. SPECIAL WARNINGS AND PRECAUTIONS FOR USE In patients with schizophrenia or other psychoses, benzod Прочитать полный документ
SG/FRI10/1022/CCDSv8.1 1. NAME OF THE MEDICINAL PRODUCTS FRISIUM ® 10MG _Clobazam _ Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg clobazam. Contains lactose (see section 4.4). For the full list of excipients, see section 6.1. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Acute and chronic anxiety states, which may produce the following symptoms in particular: Anxiety, tension, restlessness, excitement, irritability, sleep disturbances from emotional causes, psychovegetative and psychosomatic disorders (for example, in the cardiovascular or gastro-intestinal area), and emotional instability. In cases of psychovegetative and psychosomatic disorders, the doctor should investigate the possibility of an organic cause. Before treatment of anxiety states associated with emotional instability, it must first be determined whether the patient suffers from a depressive disorder requiring adjuvant of different treatment. - As adjunctive therapy in patients with epilepsy who are not adequately stabilized with their anticonvulsant mono-therapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE Pharmaceutical presentation, dosage, and duration of treatment must be adjusted to the individual clinical response, the indication, and the severity of the condition. Due regard must be paid to the possibility of interference with alertness and reaction time. The fundamental principle is to keep the dose as low as possible. When treatment with Frisium10 is to be discontinued after prolonged administration, the dosage should normally be tapered off over a period of time. _ _ _Treatment of anxiety states:_ Adults and adolescents over 15 years of age: The initial dose is usually 20mg Frisium10 daily. If necessary, the daily dose may be increase to 30mg. Generally, it is recommended that a total daily dose of 30 mg is not exceeded. Elderly: Increased responsiveness and higher susceptibility to adverse effects may be present in elderly patients and require low initial doses and gradual dose increments u Прочитать полный документ